Myanmar Pyin Oo Lwin Coffee (Coffea arabica 'Myanmar Pyin Oo Lwin')

Myanmar Pyin Oo Lwin Coffee (Coffea arabica cultivated in the Pyin Oo Lwin highlands of Myanmar) delivers caffeine and chlorogenic acids as its primary bioactive compounds, which modulate adenosine receptors and inhibit glucose-6-phosphatase to influence alertness and glucose metabolism. No cultivar-specific clinical trials exist, so health effects are extrapolated from broader Coffea arabica and chlorogenic acid research.

Origin & History

Myanmar Pyin Oo Lwin Coffee is a cultivar variant of Coffea arabica grown in the highland region of Pyin Oo Lwin, Myanmar, where the cooler climate supports high-quality Arabica production on small farms and estates. Introduced by British colonists in the early 1800s, it is wet-processed at facilities like the Mandalay Coffee Group through pulping, washing, and drying.

Historical & Cultural Context

Myanmar Pyin Oo Lwin Coffee has no documented traditional medicinal use, being primarily a commercial crop introduced in the 1800s for beverage production. The cultivar represents colonial agricultural development rather than indigenous medicinal tradition.

Health Benefits

• No clinical evidence exists for this specific cultivar - general C. arabica benefits may apply but are not verified for this variant
• Potential caffeine-related alertness effects based on general coffee research (no cultivar-specific studies)
• Possible glucose metabolism support via chlorogenic acids found in standard C. arabica (no cultivar-specific data)
• May contain antioxidant polyphenols typical of C. arabica (no quantitative analysis available)
• Theoretical adenosine receptor modulation effects from caffeine content (no clinical verification for this variant)

How It Works

Caffeine in Coffea arabica competitively antagonizes adenosine A1 and A2A receptors in the central nervous system, reducing inhibitory neurotransmission and increasing dopaminergic and noradrenergic signaling to promote wakefulness. Chlorogenic acids, particularly 5-caffeoylquinic acid, inhibit the enzyme glucose-6-phosphatase in the liver, potentially blunting postprandial glucose spikes by slowing hepatic glucose release. Additionally, chlorogenic acids may activate AMP-activated protein kinase (AMPK), a key regulator of cellular energy homeostasis, though this has not been confirmed in this specific cultivar.

Scientific Research

No clinical trials, RCTs, or meta-analyses specific to Myanmar Pyin Oo Lwin Coffee were identified in PubMed or other databases. All available evidence relates to general Coffea arabica studies rather than this specific cultivar variant.

Clinical Summary

No peer-reviewed clinical trials have been conducted specifically on Myanmar Pyin Oo Lwin Coffee or its extracts, making cultivar-specific efficacy claims unsupported by direct evidence. General Coffea arabica research, including randomized controlled trials in cohorts of 50–200 participants, has associated chlorogenic acid intake (200–400 mg/day) with modest reductions in fasting blood glucose of approximately 5–10 mg/dL. Meta-analyses of coffee consumption studies suggest a dose-dependent association with reduced type 2 diabetes risk, but these findings cannot be attributed to this specific highland Myanmar cultivar without independent phytochemical profiling and clinical testing. Evidence quality for this particular ingredient remains very low, and all purported benefits are extrapolated from general Arabica coffee literature.

Nutritional Profile

{"macronutrients": {"carbohydrates": "0.2g per 100ml brewed coffee", "protein": "0.1g per 100ml brewed coffee", "fat": "0g per 100ml brewed coffee"}, "micronutrients": {"potassium": "116mg per 100ml brewed coffee", "magnesium": "7mg per 100ml brewed coffee", "niacin (Vitamin B3)": "0.5mg per 100ml brewed coffee"}, "bioactive_compounds": {"caffeine": "40mg per 100ml brewed coffee", "chlorogenic acids": "70mg per 100ml brewed coffee", "polyphenols": "80mg per 100ml brewed coffee"}, "bioavailability_notes": "The bioavailability of caffeine and chlorogenic acids can vary based on brewing method and individual metabolism. Polyphenols are generally well-absorbed but can be influenced by the presence of other dietary components."}

Preparation & Dosage

No clinically studied dosage ranges exist for this specific cultivar. General C. arabica coffee consumption is typically 1-3 cups daily (70-210 mg caffeine), but standardization data for Pyin Oo Lwin variants is unavailable. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

L-theanine, green tea extract, guarana, rhodiola, ginseng

Safety & Interactions

As a Coffea arabica cultivar, Myanmar Pyin Oo Lwin Coffee carries caffeine-related risks including anxiety, insomnia, tachycardia, and elevated blood pressure at doses exceeding 400 mg caffeine per day in healthy adults. It may interact with anticoagulants such as warfarin, as chlorogenic acids can modestly affect platelet aggregation, and caffeine can increase the clearance of clozapine and other CYP1A2-metabolized drugs. Pregnant individuals are advised to limit total caffeine intake to under 200 mg per day due to associations between high caffeine exposure and reduced fetal birth weight. Individuals with anxiety disorders, cardiac arrhythmias, or gastroesophageal reflux disease should exercise caution due to caffeine's stimulant and acid-secretion-promoting properties.